Distinct HLA associations by stroke subtype in children with sickle cell anemia.

Children with sickle cell anemia (SCA) carry a 200-fold increased risk for cerebral infarction. Stroke can be the result of small-vessel (SV) or large-vessel (LV) disease. However, it is unknown whether these subtypes result from the same pathophysiologic processes. Complete HLA genotyping was performed on 231 eligible children previously enrolled in the Cooperative Study of Sickle Cell Disease (CSSCD). Cerebral infarction on magnetic resonance imaging (MRI) was documented in 71 patients, and 160 patients had negative findings on MRI. Based on MRI/magnetic resonance angiography (MRA) findings, infarct size, and location, 36 patients were classified as having LV stroke and 35 as having SV stroke. When comparing the total MRI+ group with the MRI- group, HLA DPB1*0401 was associated with increased stroke risk (P =.01), whereas DPB1*1701 (P =.02) conferred protection from stroke. These DPB1 associations with stroke were attributed to the SV stroke group, in whom DPB1*0401 was associated with susceptibility (P =.003) and DPB1*1701 with protection from stroke (P =.06). In the LV stroke subgroup, HLA-A*0102 (P =.02) and -A*2612 (P =.007) conferred susceptibility, whereas -A*3301(P =.04) protected from stroke. These results suggest that specific HLA alleles influence stroke risk and appear to contribute differently to SV and LV stroke subtypes. The distinct HLA associations with SV and LV stroke suggest that different pathologic processes may be involved in the development of stroke in children with SCA. If these results are confirmed in a larger study, HLA type may serve as a useful marker for the early identification of SCA patients at high risk for stroke.

[1]  W. O'Fallon,et al.  Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms. , 2002, Journal of vascular surgery.

[2]  S. Ballas,et al.  Molecular characteristics of pediatric patients with sickle cell anemia and stroke , 2001, American journal of hematology.

[3]  J J Goedert,et al.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.

[4]  N Risch,et al.  Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. , 2001, American journal of human genetics.

[5]  G. Vercellotti,et al.  Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. , 2000, Blood.

[6]  J. Elion,et al.  Acute clinical events in 299 homozygous sickle cell patients living in France , 2000, European journal of haematology.

[7]  W. Klitz,et al.  Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. , 2000, Blood.

[8]  Jenifer L. Breshears Silent Cerebral Infarcts in Sickle Cell Anemia: A Risk Factor Analysis. , 2000 .

[9]  E. Karita,et al.  HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. , 1999, AIDS research and human retroviruses.

[10]  Scott T. Miller,et al.  Cerebrovascular accidents in sickle cell disease: rates and risk factors. , 1998, Blood.

[11]  M. Fukui,et al.  Analysis of class II genes of human leukocyte antigen in patients with Moyamoya disease , 1997, Clinical Neurology and Neurosurgery.

[12]  L. Walsh,et al.  Ischemic strokes in children , 1997, Indian journal of pediatrics.

[13]  W R Mayr,et al.  Nomenclature for Factors of the HLA System, 1996 , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[14]  Scott T. Miller,et al.  The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. , 1996, AJNR. American journal of neuroradiology.

[15]  M. Carrington,et al.  Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. , 1995, American journal of human genetics.

[16]  G. Serjeant Natural history and determinants of clinical severity of sickle cell disease , 1995, Current opinion in hematology.

[17]  Qingbo Xu,et al.  Is atherosclerosis an immunologically mediated disease? , 1995, Immunology today.

[18]  H. Erlich,et al.  A method for typing polymorphism at the HLA-A locus using PCR amplification and immobilized oligonucleotide probes. , 1994, Tissue antigens.

[19]  G. Dahlén,et al.  Importance of Lp(a) lipoprotein and HLA genotypes in atherosclerosis and diabetes , 1994, Clinical genetics.

[20]  R J Adams,et al.  Alpha thalassemia and stroke risk in sickle cell anemia , 1994, American journal of hematology.

[21]  H. Erlich,et al.  Efficient typing of the HLA-B locus using the PCR and immobilized oligonucleotide probes , 1994 .

[22]  G. Dahlén,et al.  Lp(a) LIPOPROTEIN AND HLA‐DR GENOTYPE IN EARLY CORONARY ARTERY DISEASE , 1993, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[23]  K. Ohene‐Frempong Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. , 1991, Seminars in hematology.

[24]  J. Adams Cerebral infarction—its pathogenesis and interpretation , 1989, The Journal of pathology.

[25]  J. Mohr,et al.  Brain infarction in sickle cell anemia: Magnetic resonance imaging correlates , 1988, Annals of neurology.

[26]  J. Verter,et al.  Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD). , 1987, Controlled clinical trials.

[27]  T. Kinney,et al.  Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with sickle cell disease. , 1985, Journal of chronic diseases.

[28]  Robert R. Sokal,et al.  The Principles and Practice of Statistics in Biological Research. , 1982 .

[29]  W. Rosse,et al.  The cooperative study of sickle cell disease: review of study design and objectives. , 1982, The American journal of pediatric hematology/oncology.

[30]  C. Pegelow,et al.  The natural history of stroke in sickle cell disease. , 1978, The American journal of medicine.

[31]  M. Torres,et al.  Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.

[32]  Steven G.E. Marsh,et al.  Nomenclature for factors of the HLA system , 1975 .

[33]  D. Powars Natural history of sickle cell disease--the first ten years. , 1975, Seminars in hematology.

[34]  F. James Rohlf,et al.  Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .